Nanoparticle albumin-bound paclitaxel versus solvent-based paclitaxel in breast cancer: A protocol for systemic review and meta-analysis.

MLA

Bingxue Li, et al. “Nanoparticle Albumin-Bound Paclitaxel versus Solvent-Based Paclitaxel in Breast Cancer: A Protocol for Systemic Review and Meta-Analysis.” Medicine, vol. 100, no. 7, Feb. 2021, pp. 1–5. EBSCOhost, https://doi.org/10.1097/MD.0000000000024514.

APA

Bingxue Li, Xinjie Chen, Tongjing Ding, Yihua Liu, Tingting Ma, Ganlin Zhang, Xiaomin Wang, Li, B., Chen, X., Ding, T., Liu, Y., Ma, T., Zhang, G., & Wang, X. (2021). Nanoparticle albumin-bound paclitaxel versus solvent-based paclitaxel in breast cancer: A protocol for systemic review and meta-analysis. Medicine, 100(7), 1–5. https://doi.org/10.1097/MD.0000000000024514

Chicago

Bingxue Li, Xinjie Chen, Tongjing Ding, Yihua Liu, Tingting Ma, Ganlin Zhang, Xiaomin Wang, et al. 2021. “Nanoparticle Albumin-Bound Paclitaxel versus Solvent-Based Paclitaxel in Breast Cancer: A Protocol for Systemic Review and Meta-Analysis.” Medicine 100 (7): 1–5. doi:10.1097/MD.0000000000024514.